Guest guest Posted August 4, 2010 Report Posted August 4, 2010 What kind of justice is there besides violence for these devils? I only pray that their families have been ruined by their own medicines. > > > The drug companies have no interest in medicine, only profit. They > couldn't care less how many lives they ruin, or how many people they > kill, just as long as they get away with it for long enough to make some > seious money out of it. One way to stop this madness is to make > directors personally responsible for the crimes their companies commit > and to remove limited liabilty from shareholders so that they could > stand to lose all their invested money in a company if it acts illegally > or knowingly causes blatent serious harm and this money then used for > compensation. Read on: > > http://www.nytimes.com/2010/07/13/health/policy/13avandia.html?_r=1 > <http://www.nytimes.com/2010/07/13/health/policy/13avandia.html?_r=1> > > Diabetes Drug Maker Hid Test Data, Files Indicate > By GARDINER HARRIS > <http://topics.nytimes.com/top/reference/timestopics/people/h/gardiner_h\ > arris/index.html?inline=nyt-per> Published: July 12, 2010 > In the fall of 1999, the drug giant Kline Beecham secretly began a > study to find out if its diabetes > <http://health.nytimes.com/health/guides/disease/diabetes/overview.html?\ > inline=nyt-classifier> medicine, Avandia > <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthto\ > pics/avandiadrug/index.htm?inline=nyt-classifier> , was safer for the > heart than a competing pill, Actos, made by Takeda. > > Avandia's success was crucial to Kline, whose labs were > otherwise all but barren of new products. But the study's results, > completed that same year, were disastrous. Not only was Avandia no > better than Actos, but the study also provided clear signs that it was > riskier to the heart. > > But instead of publishing the results, the company spent the next 11 > years trying to cover them up, according to documents recently obtained > by The New York Times. The company did not post the results on its Web > site or submit them to federal drug regulators, as is required in most > cases by law. > > But the latest documents demonstrate that the company had data hinting > at Avandia's extensive heart problems almost as soon as the drug was > introduced in 1999, and sought intensively to keep those risks from > becoming public. In one document, the company sought to quantify the > lost sales that would result if Avandia's cardiovascular safety risk > " intensifies. " The cost: $600 million from 2002 to 2004 alone, > the document stated. > > But after GlaxoKline was found in 2004 to have hidden data that > showed that its antidepressant, Paxil > <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthto\ > pics/paxil_drug/index.html?inline=nyt-classifier> , led children and > teenagers to have more suicidal > <http://health.nytimes.com/health/guides/disease/suicide-and-suicidal-be\ > havior/overview.html?inline=nyt-classifier> thoughts and behaviors, the > company settled a lawsuit by agreeing to publicly post data from all of > its trials. In 2007, Congress mandated such disclosures. But the > postings are often little more than cryptic references, so the issue is > far from resolved. > > Kaivey > Quote
Guest guest Posted August 4, 2010 Report Posted August 4, 2010 I agree. > > > > > > The drug companies have no interest in medicine, only profit. They > > couldn't care less how many lives they ruin, or how many people they > > kill, just as long as they get away with it for long enough to make some > > seious money out of it. One way to stop this madness is to make > > directors personally responsible for the crimes their companies commit > > and to remove limited liabilty from shareholders so that they could > > stand to lose all their invested money in a company if it acts illegally > > or knowingly causes blatent serious harm and this money then used for > > compensation. Read on: > > > > http://www.nytimes.com/2010/07/13/health/policy/13avandia.html?_r=1 > > <http://www.nytimes.com/2010/07/13/health/policy/13avandia.html?_r=1> > > > > Diabetes Drug Maker Hid Test Data, Files Indicate > > By GARDINER HARRIS > > <http://topics.nytimes.com/top/reference/timestopics/people/h/gardiner_h\ > > arris/index.html?inline=nyt-per> Published: July 12, 2010 > > In the fall of 1999, the drug giant Kline Beecham secretly began a > > study to find out if its diabetes > > <http://health.nytimes.com/health/guides/disease/diabetes/overview.html?\ > > inline=nyt-classifier> medicine, Avandia > > <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthto\ > > pics/avandiadrug/index.htm?inline=nyt-classifier> , was safer for the > > heart than a competing pill, Actos, made by Takeda. > > > > Avandia's success was crucial to Kline, whose labs were > > otherwise all but barren of new products. But the study's results, > > completed that same year, were disastrous. Not only was Avandia no > > better than Actos, but the study also provided clear signs that it was > > riskier to the heart. > > > > But instead of publishing the results, the company spent the next 11 > > years trying to cover them up, according to documents recently obtained > > by The New York Times. The company did not post the results on its Web > > site or submit them to federal drug regulators, as is required in most > > cases by law. > > > > But the latest documents demonstrate that the company had data hinting > > at Avandia's extensive heart problems almost as soon as the drug was > > introduced in 1999, and sought intensively to keep those risks from > > becoming public. In one document, the company sought to quantify the > > lost sales that would result if Avandia's cardiovascular safety risk > > " intensifies. " The cost: $600 million from 2002 to 2004 alone, > > the document stated. > > > > But after GlaxoKline was found in 2004 to have hidden data that > > showed that its antidepressant, Paxil > > <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthto\ > > pics/paxil_drug/index.html?inline=nyt-classifier> , led children and > > teenagers to have more suicidal > > <http://health.nytimes.com/health/guides/disease/suicide-and-suicidal-be\ > > havior/overview.html?inline=nyt-classifier> thoughts and behaviors, the > > company settled a lawsuit by agreeing to publicly post data from all of > > its trials. In 2007, Congress mandated such disclosures. But the > > postings are often little more than cryptic references, so the issue is > > far from resolved. > > > > Kaivey > > > Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.